nabu.science
MethodologyAboutContact

 

Reliability concern: This paper was retracted on 2023-10-18. See notice: 10.1155/2023/9894170.

  • Snapshot
  • Key Claims
  • Strengths & Limitations
  • Commentary
  • From the Authors
  • Author Note / Field Feedback
  • Dimension breakdown
  • Impact Profile
Free · About 5 minutes
Report #NBU-5A6F9BBB·Framework v5.0·Pipeline v0.4·Evaluated 01 Jun 2026·OECD: 3.1 Basic medicine·Subfield: Pulmonary and Respiratory Medicine·Basis: Full text·Type: Diagnostic accuracy study

Diagnostic Value of Endoscopic Narrow-Band Imaging Technique in Early Gastric Cancer and Precancerous Lesions.

Huang et al.Huang, Chen, Zhao·2022·Scanning·10.1155/2022/9205150 ↗

In brief

Assesses NBI plus magnification for early gastric lesion diagnosis, but pervasive internal count contradictions and disease-term substitution make the reported accuracy metrics unreliable.

ReliabilityConcerns4 of 4 checks completeRead the 3 entries ↓
Abstract

OBJECTIVE: To investigate the diagnostic value of endoscopic narrow-band imaging technique in early gastric cancer and precancerous lesions.

METHODS: A total of 100 patients with recurrent upper gastrointestinal symptoms in our hospital from January 2017 to January 2022 were selected and divided into group A and group B according to the random number table method, with 50 cases in each group. Group A received white light endoscopy, and group B received narrow-band imaging technology combined with endoscopy. Narrow-band imaging combined with magnifying endoscopy was used to stain the area with suspicious mucosal lesions with indigo carmine and magnified observation.

RESULTS: The endoscopic image clarity of group B was significantly better than that of group A in terms of lesion outline, gastric pit, and microvascular morphology (P < 0.05). There were 10 cases of early gastric cancer, 18 cases of benign lesions, and 9 cases of gastric cancer (nonearly stage); 17 cases of precancerous lesions, 12 cases of early gastric cancer, 13 cases of benign lesions, and 6 cases of gastric cancer (nonearly stage) were diagnosed by ordinary white light endoscopy. Pathological results confirmed that among the 50 patients in group B, there were 15 cases of precancerous lesions, 11 cases of early gastric cancer, 17 cases of benign lesions, and 7 cases of gastric cancer (nonearly stage). Among the 50 patients in group A, 16 were precancerous lesions, 11 were early gastric cancer, 15 were benign lesions, and 8 were gastric cancer (non early stage). In the diagnosis of precancerous lesions and early gastric cancer, the diagnostic consistency, sensitivity, and specificity of group B were better than those of group A (P < 0.05); NBI combined with endoscopy in the diagnosis of precancerous lesions and early gastric cancer (kappa = 0.860, kappa = 0.883) was more consistent with pathological diagnosis than common white light endoscopy (kappa = 0.433, kappa = 0.535).

CONCLUSION: The value of narrow-band imaging technology combined with endoscopy in the diagnosis of precancerous lesions and early gastric cancer is better than that of ordinary white light endoscopy, and it can be widely used in clinical practice.

Strengths · Limitations

Strengths

#methodological rigour

Histopathology reference standard stated

The study explicitly defines histopathology as the “gold standard” for diagnosis, which is the appropriate anchor for evaluating endoscopic diagnostic performance.

↳ Methods §2.2

#methodological rigour

Operational diagnostic criterion described

Use of the VS classification criteria (demarcation line with irregular microsurface or microvascular pattern) provides a recognizable rule for classifying lesions during NBI assessment.

↳ Methods §2.2–§2.3

#application pathway

Clinically relevant detection problem

The manuscript targets early gastric cancer and precancerous lesion detection during endoscopy, a well-recognized clinical need described in the Introduction and Discussion.

↳ Introduction §1; Discussion §4

Limitations

#reporting

Contradictory core case counts

Pathology distributions for Group A differ between the Abstract and Results §3.2, and Group A numbers appear inside the Group B subsection (§3.3), undermining confidence in the reported accuracy calculations.

↳ Abstract; Results §3.2–§3.3

#reporting

Systematic disease-term substitution

Multiple sections refer to “leukemia” in contexts where gastric cancer is intended, including Results and Discussion, which materially confuses what condition the metrics describe.

↳ Introduction §1; Results §3.3–§3.4; Discussion §4

#positioning

Limited conduct transparency

Ethics approval is declared without an identifiable board or approval number, and data are only available “upon request,” limiting verifiability.

↳ Methods §2.1; Data Availability Statement

Does this match your read? Add your assessment ↓

Withdrawn — shown for reference only

Nabu Commentary

The manuscript’s central comparison is straightforward and clinically relevant, and it describes a recognizable diagnostic criterion (VS classification) with histopathology as the reference (Methods §2.2). However, key numerical results are internally inconsistent between the Abstract and Results (§3.2–§3.3), and the text repeatedly substitutes the disease entity with “leukemia” across Results/Discussion, which undermines interpretability of the main outcomes. Sensitivity and specificity are referenced as being in Table 6 (Results §3.4) without enough narrative detail to independently reconcile calculations from the provided text. These issues drive a low craft/clarity assessment and a Red reliability flag, even though the clinical impact pathway for NBI in endoscopy is plausible in principle.

Evaluate another paper

Free · About 5 minutes · Research preview

Author Note / Field Feedback

Nabu’s assessment, alongside the field’s view.

Are you an author of this paper?

Dimension breakdown

Evidence Score

Out of 5
012345
2.1±0.2

Contribution
2.3

The study addresses an established diagnostic question (NBI vs white-light endoscopy) and appears to replicate a known direction of effect, so its advance is incremental. Internal inconsistencies in the reported distributions limit its utility as a reliable additional data point.

Abstract; Results §3.2–§3.4; Discussion §4

"NBI combined with endoscopy ... was more consistent with pathological diagnosis"

Methodological Rigour
2.0

Methods describe random allocation and histopathology as reference standard, but key reporting deficiencies and internal contradictions reduce confidence in execution (Abstract vs Results §3.2–§3.3) and suggest potential verification/workup bias via targeted biopsy language (Methods §2.2). Because reliability is Red, the craft score is capped at 2.0 (uncapped merit estimate 2.2).

Methods §2.1–§2.2; Results §3.2–§3.4

"A precise biopsy is performed on the site of the most visible lesion."

Reporting
2.1

The paper’s structure is recognizable, but comprehension is substantially impaired by repeated disease-term substitution ("leukemia") and contradictory group counts that a reader cannot reconcile from the narrative alone. The conclusion also overreaches toward broad clinical use without bounds.

Introduction §1; Results §3.2–§3.4; Discussion §4; Conclusions §5

"11 patients with early leukemia"

Positioning
2.2

Background and discussion include standard framing (Correa cascade, NBI optics rationale, VS classification) and cite prior studies, supporting basic contextual grounding. However, engagement with diagnostic-accuracy reporting norms and limitations is not developed, reducing contextual interpretability.

Introduction §1; Methods §2.2; Discussion §4

"VS classification method ... lesions with a clear demarcation line"

Lower confidence on Methodological Rigour — domain match limited.

Reliability

Concerns4 of 4 checks


Internal CoherenceConcern

Key numerical results and disease labels are internally inconsistent across the Abstract and Results, and multiple sections contain systematic terminology substitutions (e.g., "leukemia") that obscure what condition is being analyzed.

Research ConductNoted

Ethics and consent are declared, but approvals are not identifiable/verifiable from the manuscript; transparency is limited because data are only available on request and no registration or COI disclosure is provided in the supplied text.

Flags: 2 declared / 5 total

Reference IntegrityClean

All 28 cited references resolved to real publications via PubMed, Crossref, or OpenAlex.

References not verified automatically are resolved manually within 24 hours.

Post-Publication RecordConcern

This paper was retracted on 2023-10-18. See notice: 10.1155/2023/9894170.

Last checked: 17 Oct 2026

Sources: Crossref (incl. Retraction Watch) ✓

Impact Profile

Impact areaHealth · Cancer and neoplasms · Stomach cancer
Type of advanceEmpirical
Route to useNamed
AdvanceConsolidates
BeneficiariesLarge
CitationsFWCI 0.5
Policy · patentNot yet traced
ReachedNot reachedNot assessable or unverified
ReadinessPiloted
Foundational
Controlled
Piloted
Validated
Implementable
FoundationalImplementable

The primary claim rests on a single-centre randomised comparison of only 100 patients, a small pilot-scale study rather than independent, multicentre, or real-world validation.

From the paper
“and it can be widely used in clinical practice”

The paper names clinical practice as the setting where its diagnostic findings would be applied, with endoscopists using NBI to guide lesion diagnosis and targeted biopsy.

Pathway

Endoscopists and gastroenterology services would adopt NBI with magnifying endoscopy to detect precancerous lesions and early gastric cancer earlier, enabling timely endoscopic treatment.

Barrier

Evidence comes from a single-centre study of only 100 patients, so larger multicentre validation and operator training are needed before routine clinical adoption.

Evaluated 13 Nov 2026 · GBD 2023 · glm_v1_3_3 · impact_profile_v1_3_3

Report an issue →

AI-generated, human-governed. Something look off? Contact us to request a review.

Keep reading

Related evaluations

Other papers Nabu has evaluated blind, starting with the same field.

  1. Implications of Cranial Arterial Stenosis and Dolichoectasia for Cerebral Small-Vessel Disease Etiopathogenesis: Findings From a Prospective Mild Stroke Cohort

    Han, Clancy, Arteaga-Reyes, et al. · 2026 · Clinical medicine

    Primary claim

    These findings support a nonatheromatous, intrinsic microvascular pathology, particularly segmental arteriolar disorganization, as the principal mechanism of lacunar stroke and cSVD.

    Tentative
    Evidence Score
    3.4±0.1
    Reliability
    Caveats
  2. A generative AI-discovered TNIK inhibitor for idiopathic pulmonary fibrosis: a randomized phase 2a trial

    Xu, Ren, Wang, et al. · 2025 · Basic medicine

    Primary claim

    We observed increased forced vital capacity at the highest dosage with a mean change of +98.4 ml (95% confidence interval 10.9 to 185.9) for patients in the 60 mg rentosertib QD group

    Tentative
    Evidence Score
    3.4±0.2
    Reliability
    Concerns
  3. C9ORF72 repeat expansion causes vulnerability of motor neurons to Ca2+-permeable AMPA receptor-mediated excitotoxicity

    Selvaraj, Livesey, Zhao, et al. · 2018 · Basic medicine

    Primary claim

    increased expression of GluA1 AMPA receptor (AMPAR) subunit occurs in MNs with C9ORF72 mutations that leads to increased Ca2+-permeable AMPAR expression and results in enhanced selective MN vulnerability to excitotoxicity.

    Tentative
    Evidence Score
    3.1±0.2
    Reliability
    Caveats

How the rubric works →